No abstract available
MeSH terms
-
Aged
-
Benzhydryl Compounds / therapeutic use*
-
Body Mass Index
-
Cardiovascular Diseases / blood
-
Cardiovascular Diseases / prevention & control
-
Diabetes Mellitus, Type 2 / blood
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Female
-
Glucosides / therapeutic use*
-
Glycated Hemoglobin / metabolism
-
Hand Strength*
-
Humans
-
Hypoglycemic Agents / therapeutic use
-
Male
-
Middle Aged
-
Risk Factors
-
Sodium-Glucose Transporter 2 / metabolism
-
Sodium-Glucose Transporter 2 Inhibitors*
-
Treatment Outcome
Substances
-
Benzhydryl Compounds
-
Glucosides
-
Glycated Hemoglobin A
-
Hypoglycemic Agents
-
SLC5A2 protein, human
-
Sodium-Glucose Transporter 2
-
Sodium-Glucose Transporter 2 Inhibitors
-
empagliflozin